Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART (CLEAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01680094
Recruitment Status : Completed
First Posted : September 6, 2012
Last Update Posted : February 25, 2014
Massachusetts General Hospital
Monash University
University of Sydney
Aarhus University Hospital
Information provided by (Responsible Party):
University of Aarhus